These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38768800)

  • 1. Bladder instillations vs onabotulinumtoxinA injection for interstitial cystitis/bladder pain syndrome: a randomized clinical trial.
    Welch EK; Dengler KL; DiCarlo-Meacham AM; Wheat JE; Pekny CJ; Aden JK; Vaccaro CM
    Am J Obstet Gynecol; 2024 May; ():. PubMed ID: 38768800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Prospective, Multicenter, Double-Blind, Randomized Trial of Bladder Instillation of Liposome Formulation OnabotulinumtoxinA for Interstitial Cystitis/Bladder Pain Syndrome.
    Chuang YC; Kuo HC
    J Urol; 2017 Aug; 198(2):376-382. PubMed ID: 28202358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bladder Instillations With Triamcinolone Acetonide for Interstitial Cystitis-Bladder Pain Syndrome: A Randomized Controlled Trial.
    Cardenas-Trowers OO; Abraham AG; Dotson TK; Houlette BA; Gaskins JT; Francis SL
    Obstet Gynecol; 2021 May; 137(5):810-819. PubMed ID: 33831942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amniotic bladder therapy: six-month follow up treating interstitial cystitis/bladder pain syndrome.
    Considine J; O'Hollaren K; Radoiu C; Madan R; Liaw A; Dhar N
    Can J Urol; 2024 Jun; 31(3):11898-11903. PubMed ID: 38912944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intratrigonal OnabotulinumtoxinA Improves Bladder Symptoms and Quality of Life in Patients with Bladder Pain Syndrome/Interstitial Cystitis: A Pilot, Single Center, Randomized, Double-Blind, Placebo Controlled Trial.
    Pinto RA; Costa D; Morgado A; Pereira P; Charrua A; Silva J; Cruz F
    J Urol; 2018 Apr; 199(4):998-1003. PubMed ID: 29031769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral phenazopyridine vs intravesical lidocaine for bladder onabotulinumtoxinA analgesia: a randomized controlled trial.
    Stewart LE; Siddique M; Jacobs KM; Raker CA; Sung VW
    Am J Obstet Gynecol; 2022 Aug; 227(2):308.e1-308.e8. PubMed ID: 35580634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective, randomized trial comparing intravesical dimethyl sulfoxide (DMSO) to bupivacaine, triamcinolone, and heparin (BTH), for newly diagnosed interstitial cystitis/painful bladder syndrome (IC/PBS).
    Moss NP; Chill HH; Sand PK; Chang C; Goldberg RP; Gafni-Kane A
    Neurourol Urodyn; 2023 Mar; 42(3):615-622. PubMed ID: 36747494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liposomal bladder instillations for IC/BPS: an open-label clinical evaluation.
    Peters KM; Hasenau D; Killinger KA; Chancellor MB; Anthony M; Kaufman J
    Int Urol Nephrol; 2014 Dec; 46(12):2291-5. PubMed ID: 25209396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of treatment outcomes of interstitial cystitis with hydrodistention and bladder training by O'Leary-Sant Interstitial Cystitis Symptom and Problem Indices.
    Huang MC; Hsieh CH; Chang WC; Chang ST; Lee MS
    Taiwan J Obstet Gynecol; 2018 Oct; 57(5):718-721. PubMed ID: 30342658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of intravesical hyaluronic acid therapy on urodynamic and clinical outcomes among women with interstitial cystitis/bladder pain syndrome.
    Peng YC; Yueh-Hsia Chiu S; Feng M; Liang CC
    Taiwan J Obstet Gynecol; 2020 Nov; 59(6):922-926. PubMed ID: 33218413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeated intravesical onabotulinumtoxinA injections are effective in treatment of refractory interstitial cystitis/bladder pain syndrome.
    Kuo HC
    Int J Clin Pract; 2013 May; 67(5):427-34. PubMed ID: 23574103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation study of new clinical scoring - "Apollo Clinical Scoring system" for bladder pain syndrome/interstitial cystitis and comparison of outcome with standard "O'Leary-Sant score".
    Taneja R; Singh AK; Sharma A; Taneja N; Raheja A
    Int Urogynecol J; 2024 Jun; 35(6):1137-1144. PubMed ID: 37642668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. O'Leary-Sant Symptom Index Predicts the Treatment Outcome for OnabotulinumtoxinA Injections for Refractory Interstitial Cystitis/Bladder Pain Syndrome.
    Kuo YC; Kuo HC
    Toxins (Basel); 2015 Jul; 7(8):2860-71. PubMed ID: 26264022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early three-month report of amniotic bladder therapy in patients with interstitial cystitis/bladder pain syndrome.
    Madan R; Radoiu C; Liaw A; Lucas S; Hamada A; Dhar N
    Int Urol Nephrol; 2023 Aug; 55(8):1937-1942. PubMed ID: 37273012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reliability and validity of Turkish versions of the interstitial cystitis symptom index and interstitial cystitis problem index.
    Esen B; Obaid K; Süer E; Gökçe Mİ; Gökmen D; Bedük Y; Gülpınar Ö
    Neurourol Urodyn; 2020 Nov; 39(8):2338-2343. PubMed ID: 32846036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the Efficacy Between Transurethral Coagulation and Transurethral Resection of Hunner Lesion in Interstitial Cystitis/Bladder Pain Syndrome Patients: A Prospective Randomized Controlled Trial.
    Ko KJ; Cho WJ; Lee YS; Choi J; Byun HJ; Lee KS
    Eur Urol; 2020 May; 77(5):644-651. PubMed ID: 31959549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretreatment features to influence effectiveness of intravesical hyaluronic Acid instillation in refractory interstitial cystitis/painful bladder syndrome.
    Kim A; Lim B; Song M; Choo MS
    Int Neurourol J; 2014 Sep; 18(3):163-7. PubMed ID: 25279245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravesical onabotulinumtoxinA injections for refractory painful bladder syndrome.
    Chung SD; Kuo YC; Kuo HC
    Pain Physician; 2012; 15(3):197-202. PubMed ID: 22622903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced versus standard intradetrusor OnabotulinumtoxinA injections for treatment of overactive bladder.
    DiCarlo-Meacham AM; Dengler KL; Welch EK; Brooks DI; Gruber DD; Osborn DJ; Scarlotta L; Vaccaro CM
    Neurourol Urodyn; 2023 Jan; 42(1):366-374. PubMed ID: 36455284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How Intravesical Platelet-Rich Plasma Can Help Patients with Interstitial Cystitis/Bladder Pain Syndrome: A Comprehensive Scoping Review.
    Soliman A; Adel M; Elnagar MA; Elsonbaty S; Hefnawy AE
    Int Urogynecol J; 2024 Sep; 35(9):1735-1743. PubMed ID: 38958727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.